hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma

doi:10.3748/wjg.v23.i9.1568

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8257)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

522

WORD

347

HTML

4644

Figures (1-4)

283

Tables (1-2)

243

Sum=6039

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

817

Download

1401

Sum=2218

Mar 7, 2017 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 7, 2017; 23(9): 1568-1575
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1568

Full Size Figure Download Figure

Figure 2 Differential DNA methylation at hsa-mir-183 promoter in primary hepatocellular carcinoma specimens compared to the adjacent liver tissues. High-resolution quantitative DNA methylation analysis using pyrosequencing shows 30% of HCC samples with hypermethylation. "Hypermethylation" was defined as described in Materials and Methods. HCC: Hepatocellular carcinoma.

Citation: Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U. hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(9): 1568-1575
URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1568.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1568